IP Verse

Pfizer patent opposition analysis

Get complete Patent Opposition Report for Pfizer

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Pfizer

Explore patent oppositions filed by Pfizer against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP4032979Factor Ix Polypeptide Mutant, Its Uses And A Method For Its ProductionUNIQURE BIOPHARMAJan 31, 2025
EP3638696Use Of Anti Cd70 Antibody Argx-110 To Treat Acute Myeloid LeukaemiaARGENXDec 6, 2024
EP3596123Fc-Optimized Anti-Cd25 For Tumour Specific Cell DepletionCANCER RESEARCH TECHNOLOGYOct 4, 2024
EP3513802Vector For Liver-Directed Gene Therapy Of Hemophilia And Methods And Use ThereofVRIJE UNIVERSITEIT BRUSSELAug 27, 2024
EP3227333Bispecific Antibodies Against Cd3Epsilon And Bcma For Use In Treatment Of DiseasesBRISTOL MYERS SQUIBBMay 16, 2024
EP3007724Compositions And Methods Of Immunizing Against C. DifficileSANOFI PASTEURApr 5, 2024
EP4108769A Method For Producing And Purifying Rna, Comprising At Least One Step Of Tangential Flow FiltrationCUREVAC MANUFACTURINGFeb 29, 2024
EP3625345Modified Messenger Rna Comprising Functional Rna ElementsMODERNATXFeb 26, 2024
EP4023755Artificial Nucleic Acid Molecules For Improved Protein ExpressionCUREVACJan 26, 2024
EP3581650Factor Ix Polypeptide Mutant, Its Uses And A Method For Its ProductionUNIQURE BIOPHARMASep 27, 2023

Latest patents of Pfizer opposed by its competitors

Explore Pfizer's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3781132Mar 20, 2024Apixaban Formulations1
EP3977993Jan 31, 2024Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-Benzoxazole For Use As A Medicament2
EP3583947Oct 11, 2023Streptococcus Pneumoniae Capsular Polysaccharides And Conjugates Thereof2
EP2134702Aug 30, 2023Crystalline Forms Of 6-[2-(Methylcarbamoyl)Phenylsulfanyl]-3-E-[2-(Pyridin-2-Yl)Ethenyl]Indazole Suitable For The Treatment Of Abnormal Cell Growth In Mammals1
EP3269717Aug 9, 2023Polymorphic And Pseudopolymorphic Forms Of Pharmaceutical Compound Nxl1041
EP3555064Mar 1, 2023Glp-1 Receptor Agonists And Uses Thereof1
EP3191461Nov 3, 2021Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-Benzoxazole5
EP2357250Oct 6, 2021Production Of Polypeptides2
EP3498734Sep 1, 2021Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer7
EP3431475Apr 7, 2021Solid Forms Of A Selective Cdk4/6 Inhibitor4

Top competitors of Pfizer